FindTrial
Sign In

Effect of yoga on altered mental process due to chemotherapy in lung cancer patients

Effectiveness of yoga on patients with chemotherapy induced cognitive impairment(CICI) in lung cancer at tertiary care center, Mumbai- A pilot study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071133
Enrollment
30
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

Intervention1: Interventions: 1. Superbrain yoga 2. Bhastrika 3. Kapalabhati 4. Bhramari 5. Siddha walk.: 1. SELECTION OF PARTICIPANT Participants will be selected those meeting inclusion and exclusio

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients histologically proven with lung cancer with/without metastasis. 2. Age 18-60 years. 3. Patients receiving chemotherapy alone/with immunotherapy/targeted therapy 4. Patients who are able to implement the planned interventional exercises. 5. Patients able to sign and understand informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients receiving only immunotherapy/targeted therapy 2. Pre existing cognitive impairment (dementia, Alzheimer’s, epilepsy, Parkinson’s, traumatic brain injury, stoke related cognitive dysfunction) 3. Patients planned for therapy with palliative intent. 4. Patients with complications (neutropenia, febrile neutropenia, pneumothorax, pain, thrombocytopenia, peripheral neuropathy)

Design outcomes

Primary

MeasureTime frame
Primary objective: • To assess the effect of yoga on patients with chemotherapy induced cognitive impairment in lung cancer from baseline to day 30. Timepoint: Day 0, Day 21, Day 30—

Secondary

MeasureTime frame
• To identify the degree of cognitive impairment and to see the trend of changes in cognition measured by ACE III scale from baseline to day 21 and from baseline to day 30 among patients with lung cancer at tertiary care center. • To compare the association between the cognitive function and the clinical data of patients with lung cancer at tertiary care center. Timepoint: Baseline to day 21 and baseline to day 30—

Countries

India

Contacts

Public ContactMiss Jimli Daimari

College of Nursing, Tata Memorial Hospital, Mumbai

prathepa_jagadish@rediffmail.com9869220441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026